Literature DB >> 9115272

Secondary dimerization between members of the epidermal growth factor receptor family.

D C Gamett1, G Pearson, R A Cerione, I Friedberg.   

Abstract

Growth factor receptors of the epidermal growth factor (EGF) receptor family play pivotal roles in the regulation of cell proliferation and differentiation and are involved in the development of human cancers. It has been well documented that these receptors undergo growth factor-stimulated homo- and heterodimerization as a first step in the initiation of signaling cascades. Here we provide evidence for a new mechanism for growth factor-stimulated receptor dimer formation, designated secondary dimerization. The growth factor-induced dimerization and ensuing receptor trans-autophosphorylation results in the dissociation of the original (primary) receptor dimer. Each phosphorylated receptor monomer then interacts with a new (nonphosphorylated) receptor to form a secondary dimer. Treatment of cells with EGF yields Neu-ErbB3 secondary dimers, and heregulin treatment induces the formation of Neu-EGF receptor (secondary) dimers. The ability of EGF and heregulin to stimulate a cascade of dimerization events points to a novel mechanism by which multiple signaling activities and diverse biological responses are initiated by members of the EGF receptor family.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115272     DOI: 10.1074/jbc.272.18.12052

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system.

Authors:  Jennifer L Macdonald; Linda J Pike
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-28       Impact factor: 11.205

2.  Extracellular domains drive homo- but not hetero-dimerization of erbB receptors.

Authors:  K M Ferguson; P J Darling; M J Mohan; T L Macatee; M A Lemmon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

3.  Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.

Authors:  S W Stoll; S Kansra; S Peshick; D W Fry; W R Leopold; J F Wiesen; M Sibilia; T Zhang; Z Werb; R Derynck; E F Wagner; J T Elder
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

4.  Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.

Authors:  Chengfeng Yang; Ying Liu; Mark A Lemmon; Marcelo G Kazanietz
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

5.  Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction.

Authors:  G C Huang; X Ouyang; R J Epstein
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

6.  Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation.

Authors:  S K Kuwada; X Li
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

7.  EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt.

Authors:  Rosa M Martín-Orozco; Carmén Almaraz-Pro; F Javier Rodríguez-Ubreva; M Alicia Cortés; Santiago Ropero; Ramón Colomer; Pilar López-Ruiz; Begoña Colás
Journal:  Neoplasia       Date:  2007-08       Impact factor: 5.715

Review 8.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

9.  Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines.

Authors:  Mario Niepel; Marc Hafner; Emily A Pace; Mirra Chung; Diana H Chai; Lili Zhou; Birgit Schoeberl; Peter K Sorger
Journal:  Sci Signal       Date:  2013-09-24       Impact factor: 8.192

10.  HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells.

Authors:  Yi Zhang; Lee Opresko; Harish Shankaran; William B Chrisler; H Steven Wiley; Haluk Resat
Journal:  BMC Cell Biol       Date:  2009-10-31       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.